MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ATHE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alterity Therapeutics (ATHE) Ownership - Who owns Alterity Therapeutics?

Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
500 Collins Street
Phone
+61 393494906
Employees
11
Web
https://www.alteritytherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
72.57M
P/E Ratio
N/A
Total Cash
37.32M
Projected Growth
N/A
Total Debt
193.47K
Revenue
N/A
Risk (Beta)
-0.08
Dividend Yield
N/A
Total Cash/Share
2.05
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
ATHE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for ATHE
A.I. Advisor
published General Information

General Information

a developer of therapeutic drugs

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
500 Collins Street
Phone
+61 393494906
Employees
11
Web
https://www.alteritytherapeutics.com
Who owns Alterity Therapeutics? ATHE symbol Ownership - Tickeron.com